JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More
Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More
![]() ![]() |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
J.B.CHEMICALS Mar-18 |
ADCOCK INGRAM Jun-14 |
J.B.CHEMICALS/ ADCOCK INGRAM |
5-Yr Chart Click to enlarge
|
||
High | Rs | 363 | 383 | - | |
Low | Rs | 255 | 276 | - | |
Sales per share (Unadj.) | Rs | 169.1 | 113.9 | - | |
Earnings per share (Unadj.) | Rs | 16.6 | -28.7 | - | |
Cash flow per share (Unadj.) | Rs | 23.4 | -23.8 | - | |
Dividends per share (Unadj.) | Rs | 2.00 | 0 | - | |
Dividend yield (eoy) | % | 0.6 | 0 | - | |
Book value per share (Unadj.) | Rs | 172.5 | 89.4 | - | |
Shares outstanding (eoy) | m | 83.57 | 168.78 | - | |
Bonus/Rights/Conversions | BB | - | - | ||
Price / Sales ratio | x | 1.8 | 2.9 | 63.2% | |
Avg P/E ratio | x | 18.6 | -11.5 | -162.1% | |
P/CF ratio (eoy) | x | 13.2 | -13.9 | -95.3% | |
Price / Book Value ratio | x | 1.8 | 3.7 | 48.6% | |
Dividend payout | % | 12.0 | 0 | - | |
Avg Mkt Cap | Rs m | 25,827 | 55,608 | 46.4% | |
No. of employees | `000 | 3.8 | 4.3 | 87.9% | |
Total wages/salary | Rs m | 2,511 | 3,490 | 71.9% | |
Avg. sales/employee | Rs Th | 3,747.4 | 4,476.9 | 83.7% | |
Avg. wages/employee | Rs Th | 665.7 | 813.0 | 81.9% | |
Avg. net profit/employee | Rs Th | 367.8 | -1,128.1 | -32.6% |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 14,135 | 19,219 | 73.5% | |
Other income | Rs m | 366 | 135 | 271.8% | |
Total revenues | Rs m | 14,501 | 19,354 | 74.9% | |
Gross profit | Rs m | 2,178 | -3,331 | -65.4% | |
Depreciation | Rs m | 570 | 829 | 68.7% | |
Interest | Rs m | 35 | 521 | 6.7% | |
Profit before tax | Rs m | 1,940 | -4,546 | -42.7% | |
Minority Interest | Rs m | 0 | -13 | 0.0% | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 552 | 284 | 194.4% | |
Profit after tax | Rs m | 1,387 | -4,843 | -28.6% | |
Gross profit margin | % | 15.4 | -17.3 | -88.9% | |
Effective tax rate | % | 28.5 | -6.2 | -455.7% | |
Net profit margin | % | 9.8 | -25.2 | -38.9% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 10,470 | 14,076 | 74.4% | |
Current liabilities | Rs m | 2,749 | 7,920 | 34.7% | |
Net working cap to sales | % | 54.6 | 32.0 | 170.5% | |
Current ratio | x | 3.8 | 1.8 | 214.3% | |
Inventory Days | Days | 55 | 111 | 49.8% | |
Debtors Days | Days | 78 | 124 | 62.7% | |
Net fixed assets | Rs m | 5,811 | 8,205 | 70.8% | |
Share capital | Rs m | 167 | 89 | 187.3% | |
Net worth | Rs m | 14,416 | 15,085 | 95.6% | |
Long term debt | Rs m | 0 | 5,301 | 0.0% | |
Total assets | Rs m | 17,649 | 28,497 | 61.9% | |
Interest coverage | x | 56.6 | -7.7 | -731.7% | |
Debt to equity ratio | x | 0 | 0.4 | 0.0% | |
Sales to assets ratio | x | 0.8 | 0.7 | 118.8% | |
Return on assets | % | 8.1 | -15.2 | -53.1% | |
Return on equity | % | 9.6 | -32.1 | -30.0% | |
Return on capital | % | 13.7 | -19.8 | -69.1% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,231 | 1,640 | 75.0% | |
From Investments | Rs m | -208 | -504 | 41.3% | |
From Financial Activity | Rs m | -595 | 4,811 | -12.4% | |
Net Cashflow | Rs m | 427 | 5,948 | 7.2% |
Compare J.B.CHEMICALS With: MYLAN (US) ACTAVIS (US) TEVA PHARMA (Israel)
Compare J.B.CHEMICALS With: DR. REDDYS LAB TTK HEALTHCARE PANACEA BIOTECH WYETH BIOCON
Indian share markets witnessed volatile trading activity throughout the day today and ended lower.
For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.
For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.
More Views on NewsAjit Dayal on how India's vaccine strategy will impact the markets.
Narayana Murthy was one of the first unicorn founders to get the backing of this entity...
There is no stopping this 11-bagger stock from significant upside.
In this video I tell you the three Nifty ETFs I think are the best.
In this video, I'll you what I think is the real reason behind yesterday's market crash.
More